BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8879978)

  • 1. The cellular toxicity of two antitumoural agents derived from platinum, cisplatinum versus oxaliplatinum, on cultures of tubular proximal cells.
    Legallicier B; Leclere C; Monteil C; Elkaz V; Morin JP; Fillastre JP
    Drugs Exp Clin Res; 1996; 22(2):41-50. PubMed ID: 8879978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxic effect of two antitumoral agents derived from platinum, the cisplatin and the oxaliplatin on primary cultures of proximal tubular cells of the kidney in rabbits].
    Legallicier B; Leclere C; Monteil C; Morin JP; Fillastre JP
    Pathol Biol (Paris); 1993 Nov; 41(9):873-80. PubMed ID: 8121719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cis-diamminedichloroplatinum(II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture.
    Tay LK; Bregman CL; Masters BA; Williams PD
    Cancer Res; 1988 May; 48(9):2538-43. PubMed ID: 2965614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
    Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.
    Montine TJ; Borch RF
    Cancer Res; 1988 Nov; 48(21):6017-24. PubMed ID: 2458831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicine-platinum anticancer agents correlates with their chemical reactivity towards sulfur-containing nucleophiles.
    To KK; Au-Yeung SC; Ho YP
    Anticancer Drugs; 2006 Jul; 17(6):673-83. PubMed ID: 16917213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial barrier characteristics and expression of cell adhesion molecules in proximal tubule-derived cell lines commonly used for in vitro toxicity studies.
    Prozialeck WC; Edwards JR; Lamar PC; Smith CS
    Toxicol In Vitro; 2006 Sep; 20(6):942-53. PubMed ID: 16387471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum complex-induced dysfunction of cultured renal proximal tubule cells. A comparative study of carboplatin and transplatin with cisplatin.
    Courjault F; Leroy D; Coquery L; Toutain H
    Arch Toxicol; 1993; 67(5):338-46. PubMed ID: 8396390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity and nephrotoxicity of a novel platinum complex, [1,3-bis(diphenylphosphino)propane](trans-1-dach)platinum(I I) dinitrate.
    Baek MS; Rho YS; Jung JC; Chang SG; Nomura M; Miyamoto KJ
    Anticancer Res; 1997; 17(2A):955-9. PubMed ID: 9137434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 3-methoxy-2(5H)-furanone-containing extracts from Narthecium ossifragum (L.) Huds. on renal tubular cells in vitro.
    Wisløff H; Gharehnia B; Flåøyen A; Andersen KJ
    Toxicon; 2007 Mar; 49(3):368-77. PubMed ID: 17141820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to nephrotoxic ochratoxin A enhances collagen secretion in human renal proximal tubular cells.
    Sauvant C; Holzinger H; Mildenberger S; Gekle M
    Mol Nutr Food Res; 2005 Jan; 49(1):31-7. PubMed ID: 15580662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of cell injury after exposure to antitumor platinum derivatives in kidney tubular epithelial cells.
    Kitada N; Takara K; Itoh C; Minegaki T; Tsujimoto M; Sakaeda T; Yokoyama T
    Chemotherapy; 2008; 54(3):217-23. PubMed ID: 18560229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicodynamic evaluation of a cisplatin-chondroitin sulfate complex using a perfused kidney and human proximal tubular cells.
    Zhang JS; Kadowaki D; Nonoguchi H; Hirata S; Seo H; Imai T; Suenaga A; Giam Chuang VT; Otagiri M
    Ren Fail; 2011; 33(6):609-14. PubMed ID: 21631182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study on the synthesis of the natriuretic hormone dopamine in OK and LLC-PK1 cells.
    Soares-da-Silva P; Serrão MP; Vieira-Coelho MA
    Cell Biol Int; 1996 Aug; 20(8):539-44. PubMed ID: 8938987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of protein thiols in inhibition of sodium-coupled glucose uptake by cisplatin in renal brush-border membrane vesicles.
    Potdevin S; Courjault-Gautier F; Du Sorbier BM; Ripoche P; Toutain HJ
    J Pharmacol Exp Ther; 1998 Jan; 284(1):142-50. PubMed ID: 9435172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.
    Haschke M; Vitins T; Lüde S; Todesco L; Novakova K; Herrmann R; Krähenbühl S
    Nephrol Dial Transplant; 2010 Feb; 25(2):426-33. PubMed ID: 19736245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro study of the nephrotoxic mechanism of mercuric chloride].
    Aleo MF; Morandini F; Bettoni F; Tanganelli S; Vezzola A; Giuliani R; Steimberg N; Boniotti J; Bertasi B; Losio N; Apostoli P; Mazzoleni G
    Med Lav; 2002; 93(3):267-78. PubMed ID: 12197277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the action of antineoplastic platinum compounds with varying nephrotoxic effects].
    Bakhteeva VT; Fok EM; Lavrova EA
    Vopr Med Khim; 1996; 42(4):301-6. PubMed ID: 9254514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.